CON ("The window is closed"): In patients with cirrhosis with ascites, the clinical risks of nonselective beta-blocker outweigh the benefits and should NOT be prescribed

Clin Liver Dis (Hoboken). 2018 Jun 5;11(5):123-127. doi: 10.1002/cld.699. eCollection 2018 May.
No abstract available

Publication types

  • Review